Carbohydrate Derivatives for Use in Drug Design: Cyclic αv-Selective RGD Peptides (pages 2761–2764)Elisabeth Lohof, Eckart Planker, Christian Mang, Fred Burkhart, Michael A. Dechantsreiter, Roland Haubner, Hans-Jürgen Wester, Markus Schwaiger, Günther Hölzemann, Simon L. Goodman and Horst Kessler
Article first published online: 2 AUG 2000 | DOI: 10.1002/1521-3773(20000804)39:15<2761::AID-ANIE2761>3.0.CO;2-9
39:15<2761::AID-ANIE2761>3.0.CO;2-9/asset/image_n/ncontent.xxx?v=1&s=48857b96613eb2e5b1ca48c1d556c902d578e042)
To improve pharmacokinetic and -dynamic properties of peptidic, bioactive compounds they can be derivatized with carbohydrate building blocks. By incorporation into the peptidic backbone (see for example 1) the conformation of the pharmacophoric moieties can be influenced, while derivatization of side chains (see for example 2) mainly modifies the pharmacokinetic behavior.